Remission of myasthenia gravis following plasma-exchange.
about
Myasthenia gravisIntravenous immunoglobulin for myasthenia gravisIntravenous immunoglobulin for myasthenia gravisThe emerging diversity of neuromuscular junction disordersClinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological SocietyNeurologic indications for therapeutic plasma exchange: an update.Neurologic indications for therapeutic plasma exchange: 2011 update.Neurologic indications for therapeutic plasma exchange: 2013 update.Potential for plasma exchange in childrenImmunoadsorption plasmapheresis for severe generalised myasthenia gravis.Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.Comparative analysis of therapeutic options used for myasthenia gravis.Indications for therapeutic plasma exchange at a university hospital and a regional blood center.Myasthenia gravis--current concepts.The muscle cell.Medical science and technology at the Royal Postgraduate Medical School: the first 50 years.Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis.Pathogenesis and treatment of myasthenia gravisTissue-specific antibodies in myasthenia gravis.Therapeutic plasma exchange in the treatment of myasthenia gravis.Plasma exchange for myasthenia gravis.Outcome after thymectomy for myasthenia gravis: a retrospective review.John Newsom-Davis: clinician-scientist and so much more.Mycophenolate mofetil treatment of myasthenia gravis.Comparative effects of plasma exchange and pyridostigmine on respiratory muscle strength and breathing pattern in patients with myasthenia gravis.The role of surgery of the thymus for myasthenia gravisOcular myasthenia gravis: response to long-term immunosuppressive treatment.Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapyAnti-acetylcholine receptor antibodies.Controversies about the treatment of myasthenia gravis.Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.Treatment strategies for myasthenia gravis.The challenge of pain management in patients with myasthenia gravis.Quantitative removal of hepatitis B viral antigens from serum by a monoclonal IgM coupled to a biocompatible solid-phase support.Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis.Current and emerging treatments for the management of myasthenia gravis.Complications of apheresis.Immunoadsorption therapy in autoimmune encephalitides.Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases.
P2860
Q21202960-6A17AAF3-2BA7-4CBB-A12E-9F014EC21591Q24202443-F675C3EE-9454-458D-93FC-1ADE5B28C476Q24242078-DE12DFCC-2544-4650-9A73-889CC2A26D23Q24595915-46B9CFBF-5310-48A7-9A51-DF2D5E321115Q26765172-36386C97-D34F-4A21-BF31-8E068B761E13Q30454297-F54AFA7E-DCDF-4C13-B888-DCA8960D43FDQ30455391-B23ED238-7747-4DFF-B37A-42DB209C3964Q30458271-4E7D014F-4FEB-4B7A-80A8-CE17F8CD10D6Q33476011-51A57DAF-A26A-427C-9A66-2310D886790CQ33623758-544DB56C-0BF0-46CA-925A-BDBD7042CE73Q33651010-23446D3E-844E-4E05-BF5D-397870C6F8C9Q33979746-3DA920B5-5DF0-42F0-B6D3-F82B4F897088Q34024635-492A5A69-D93D-4F2E-8E1F-7513F5C1E2CDQ34109833-C619B73A-05F4-4275-8394-9AB35AAE5C1EQ34192385-269C0654-8E29-46C5-AD83-FB48C9012922Q34302653-79253E0C-5D48-4A8C-B390-26D0F43FF792Q34493567-B09BA5B3-988E-4B8C-8EC2-A9AE83ADE2CEQ34533028-5D9EFE75-F522-49BF-B885-7C8D33884EFDQ34784410-0CDA375A-C32E-4174-A381-4721A0395B60Q34860454-B2C202DD-0A0F-4E0C-A234-8C78836F4EBCQ34975594-718D0FA9-245A-4298-A982-53D34B5FDE67Q35041815-B766ECB1-D426-4022-8E10-9ECC51B9B3BEQ35424601-1C1B001D-95FF-4821-AAE6-C73A66F8E408Q35606729-C9A05342-7E7F-401B-8CCE-FF82BAEA6DB9Q36364969-56A08C6C-976F-4A17-B502-18CCA62F6C57Q36570265-64C43D2D-C2FF-446D-BF82-68C928F3459EQ36806665-86325AF8-156C-4948-8048-7EF65B10EC87Q36902041-21F911E0-98A9-45AF-9CCB-CC6AF3AD4EB3Q36998741-1E6B71A5-7F2C-466D-A1DB-790CA2D15871Q37000298-D94A32F1-703F-43F9-8F56-EC644CCC8BEAQ37000423-63D98B53-D1AF-414C-922B-7BCEA5991B54Q37010999-745C7605-20DB-4138-B9CA-FD2D2CD9C990Q37483922-83778628-1766-493A-A6A1-00B1EC884785Q37577775-1771ACE9-594E-454A-A948-7E3F0A3C687DQ37615617-0572ADA6-F906-4431-88A7-5822AD811505Q37699350-AA95688D-B9FD-4878-A053-C16B45ED07AFQ37918361-BD2D84AF-30EA-47B0-81E4-E3D14786A064Q37982852-F5ADF864-D427-4217-AF20-8E20616FA9E5Q38698635-18CC01B7-CBFD-4651-AA73-98BD4C9C53ECQ39134222-3198D01D-1E78-4AEC-BD66-FD049E7AE2FF
P2860
Remission of myasthenia gravis following plasma-exchange.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
Remission of myasthenia gravis following plasma-exchange.
@en
Remission of myasthenia gravis following plasma-exchange.
@nl
type
label
Remission of myasthenia gravis following plasma-exchange.
@en
Remission of myasthenia gravis following plasma-exchange.
@nl
prefLabel
Remission of myasthenia gravis following plasma-exchange.
@en
Remission of myasthenia gravis following plasma-exchange.
@nl
P1433
P1476
Remission of myasthenia gravis following plasma-exchange.
@en
P2093
A J Pinching
D K Peters
P304
P356
10.1016/S0140-6736(76)91917-6
P407
P577
1976-12-01T00:00:00Z